InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
PGN-SA peptidoglycan preparation | Paneth Cells Regulate Lymphangiogenesis under Control of Microbial Signals du... | 2022 | Biomedicines | Hassan M. et al. | DOI: 10.3390/biomedicines10071503 |
MDP | Paneth Cells Regulate Lymphangiogenesis under Control of Microbial Signals du... | 2022 | Biomedicines | Hassan M. et al. | DOI: 10.3390/biomedicines10071503 |
D614 Varient Spike Pseudotyping Vector | Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are an... | 2022 | Sci Immunol. | Mykytyn A.Z. et al. | DOI: 10.1126/sciimmunol.abq4450 |
Kappa Variant (B.1.617.1) Spike Pseudotyping Vector | Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are an... | 2022 | Sci Immunol. | Mykytyn A.Z. et al. | DOI: 10.1126/sciimmunol.abq4450 |
D614G Variant Spike Pseudotyping Vector | Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are an... | 2022 | Sci Immunol. | Mykytyn A.Z. et al. | DOI: 10.1126/sciimmunol.abq4450 |
Delta Variant (B.1.617.2) Spike Pseudotyping Vector | Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are an... | 2022 | Sci Immunol. | Mykytyn A.Z. et al. | DOI: 10.1126/sciimmunol.abq4450 |
Beta Variant (B.1.351) Spike Pseudotyping Vector | Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are an... | 2022 | Sci Immunol. | Mykytyn A.Z. et al. | DOI: 10.1126/sciimmunol.abq4450 |
Alpha Variant (B.1.1.7) Spike Pseudotyping Vector | Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are an... | 2022 | Sci Immunol. | Mykytyn A.Z. et al. | DOI: 10.1126/sciimmunol.abq4450 |
FSL-1 | TIRAP/Mal Positively Regulates TLR8-Mediated Signaling via IRF5 in Human Cells. | 2022 | Biomedicines | Nilsen K.E. et al. | DOI: 10.3390/biomedicines10071476 |
CL075 (3M002) | TIRAP/Mal Positively Regulates TLR8-Mediated Signaling via IRF5 in Human Cells. | 2022 | Biomedicines | Nilsen K.E. et al. | DOI: 10.3390/biomedicines10071476 |
Normocin® - Antimicrobial Reagent | Protein Tyrosine Phosphatase SHP2 Controls Interleukin-8 Expression in Breast... | 2022 | J Mammary Gland Biol Neoplasia | Amante R.J. et al. | DOI: 10.1007/s10911-022-09521-x |
Poly(I:C) LMW | Harnessing anti-cytomegalovirus immunity for local immunotherapy against soli... | 2022 | PNAS | Çuburu N. et al. | DOI: 10.1073/pnas.2116738119 |
G418 (Geneticin) | Harnessing anti-cytomegalovirus immunity for local immunotherapy against soli... | 2022 | PNAS | Çuburu N. et al. | DOI: 10.1073/pnas.2116738119 |
QUANTI-Blue™ | TRIM25 inhibits influenza A virus infection, destabilizes viral mRNA, but is ... | 2022 | Nucleic Acids Res | Choudhury N.R. et al. | DOI: 10.1093/nar/gkac512 |
3p-hpRNA - RIG-I agonist | TRIM25 inhibits influenza A virus infection, destabilizes viral mRNA, but is ... | 2022 | Nucleic Acids Res | Choudhury N.R. et al. | DOI: 10.1093/nar/gkac512 |
IFN-α/β Reporter HEK 293 Cells | TRIM25 inhibits influenza A virus infection, destabilizes viral mRNA, but is ... | 2022 | Nucleic Acids Res | Choudhury N.R. et al. | DOI: 10.1093/nar/gkac512 |
Poly(I:C) HMW | Human Beta Papillomavirus Type 8 E1 and E2 Proteins Suppress the Activation o... | 2022 | Viruses | Rattay S. et al. | DOI: 10.3390/v14071361 |
IFN-α/β Reporter HEK 293 Cells | Human Beta Papillomavirus Type 8 E1 and E2 Proteins Suppress the Activation o... | 2022 | Viruses | Rattay S. et al. | DOI: 10.3390/v14071361 |
Poly(I:C) HMW | Simulation of COVID-19 symptoms in a genetically engineered mouse model: impl... | 2022 | Mol Cell Biochem. | Singh M. et al. | DOI: 10.1007/s11010-022-04487-0 |
LPS-EB (LPS from E. coli O111:B4) | Distinct responses between healthy and cirrhotic human livers upon lipopolysa... | 2022 | Am J Physiol Gastrointest Liver Physiol. | Suriguga S. et al. | DOI: 10.1152/ajpgi.00243.2021 |